BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Haensele E, Mele N, Miljak M, Read CM, Whitley DC, Banting L, Delépée C, Sopkova-de Oliveira Santos J, Lepailleur A, Bureau R, Essex JW, Clark T. Conformation and Dynamics of Human Urotensin II and Urotensin Related Peptide in Aqueous Solution. J Chem Inf Model 2017;57:298-310. [DOI: 10.1021/acs.jcim.6b00706] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Wong MTY, Kelm S, Liu X, Taylor RD, Baker T, Essex JW. Higher Affinity Antibodies Bind With Lower Hydration and Flexibility in Large Scale Simulations. Front Immunol 2022;13:884110. [DOI: 10.3389/fimmu.2022.884110] [Reference Citation Analysis]
2 Reid LM, Guzzetti I, Svensson T, Carlsson AC, Su W, Leek T, von Sydow L, Czechtizky W, Miljak M, Verma C, De Maria L, Essex JW. How well does molecular simulation reproduce environment-specific conformations of the intrinsically disordered peptides PLP, TP2 and ONEG? Chem Sci 2022;13:1957-71. [PMID: 35308859 DOI: 10.1039/d1sc03496k] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Damjanovic J, Miao J, Huang H, Lin YS. Elucidating Solution Structures of Cyclic Peptides Using Molecular Dynamics Simulations. Chem Rev 2021;121:2292-324. [PMID: 33426882 DOI: 10.1021/acs.chemrev.0c01087] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 19.0] [Reference Citation Analysis]
4 Billard E, Chatenet D. Insights into the Molecular Determinants Involved in Urocontrin and Urocontrin A Action. ACS Med Chem Lett 2020;11:1717-22. [PMID: 32944139 DOI: 10.1021/acsmedchemlett.0c00223] [Reference Citation Analysis]
5 Nassour H, Iddir M, Chatenet D. Towards Targeting the Urotensinergic System: Overview and Challenges. Trends in Pharmacological Sciences 2019;40:725-34. [DOI: 10.1016/j.tips.2019.08.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
6 Huggins DJ, Biggin PC, Dämgen MA, Essex JW, Harris SA, Henchman RH, Khalid S, Kuzmanic A, Laughton CA, Michel J, Mulholland AJ, Rosta E, Sansom MSP, van der Kamp MW. Biomolecular simulations: From dynamics and mechanisms to computational assays of biological activity. WIREs Comput Mol Sci 2019;9. [DOI: 10.1002/wcms.1393] [Cited by in Crossref: 67] [Cited by in F6Publishing: 71] [Article Influence: 16.8] [Reference Citation Analysis]
7 Sun X, Chen S, Wang L, Chen Z. Total flavones of Rhododendron simsii Planch flower protect isolated rat heart from ischaemia-reperfusion injury and its mechanism of UTR-RhoA-ROCK pathway inhibition. Journal of Pharmacy and Pharmacology 2018;70:1713-22. [DOI: 10.1111/jphp.13016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
8 Douchez A, Billard E, Hébert TE, Chatenet D, Lubell WD. Design, Synthesis, and Biological Assessment of Biased Allosteric Modulation of the Urotensin II Receptor Using Achiral 1,3,4-Benzotriazepin-2-one Turn Mimics. J Med Chem 2017;60:9838-59. [DOI: 10.1021/acs.jmedchem.7b01525] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
9 Billard E, Létourneau M, Hébert TE, Chatenet D. Insight into the role of urotensin II-related peptide tyrosine residue in UT activation. Biochemical Pharmacology 2017;144:100-7. [DOI: 10.1016/j.bcp.2017.08.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]